# Starz Entertainment Corp: financial statements, quarterly

STRZ · Nasdaq · CIK 929351 · [Communication](/sectors/communication.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/strz.md) · [Financials](/companies/strz/financials.md) · [Filings](/companies/strz/filings.md) · [Insiders](/companies/strz/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/strz/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2024 (2023-12-31) | Q4 FY2024 (2024-03-31) | Q1 FY2025 (2024-06-30) | Q2 FY2025 (2024-09-30) | Q3 FY2025 (2024-12-31) | Q4 FY2025 (2025-03-31) | Q1 FY2026 (2025-06-30) | Q2 FY2026 (2025-09-30) | Q3 FY2026 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2027 (2026-06-30) | Q3 FY2027 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [975](/filings/0000929351-25-000005.md) | [(1,507) d](/filings/0000929351-26-000011.md) | [348](/filings/0000929351-25-000103.md) | [347](/filings/0000929351-25-000142.md) | [971](/filings/0000929351-25-000005.md) | [331](/filings/0000929351-26-000031.md) | [320](/filings/0001628280-26-054565.md) | [321](/filings/0000929351-26-000054.md) | [323 d](/filings/0000929351-26-000011.md) | [307](/filings/0000929351-26-000031.md) | [308](/filings/0001628280-26-054565.md) | [322](/filings/0000929351-26-000054.md) |
| Operating income | $m | [(43.5)](/filings/0000929351-25-000005.md) | [(25.6) d](/filings/0000929351-26-000011.md) | [10.1](/filings/0000929351-25-000103.md) | [(17.0)](/filings/0000929351-25-000142.md) | [35.8](/filings/0000929351-25-000005.md) | [(142)](/filings/0000929351-26-000031.md) | [(26.9)](/filings/0001628280-26-054565.md) | [(34.8)](/filings/0000929351-26-000054.md) | [(4.7) d](/filings/0000929351-26-000011.md) | [(153)](/filings/0000929351-26-000031.md) | [(176)](/filings/0001628280-26-054565.md) | [(21.2)](/filings/0000929351-26-000054.md) |
| Interest expense | $m | [67.1](/filings/0000929351-25-000005.md) | [76.9 d](/filings/0000929351-24-000012.md) | [68.8](/filings/0000929351-24-000017.md) | [74.3](/filings/0000929351-24-000023.md) | [69.1](/filings/0000929351-25-000005.md) | [10.9](/filings/0000929351-26-000031.md) | [13.2](/filings/0001628280-26-054565.md) | [15.8](/filings/0000929351-26-000054.md) | [14.2 d](/filings/0000929351-26-000011.md) | [13.9](/filings/0000929351-26-000031.md) | [13.6](/filings/0001628280-26-054565.md) | [14.0](/filings/0000929351-26-000054.md) |
| Income tax | $m | [4.7](/filings/0000929351-25-000005.md) | [(141) d](/filings/0000929351-26-000011.md) | [(7.6)](/filings/0000929351-25-000103.md) | [0.4](/filings/0000929351-25-000142.md) | [4.0](/filings/0000929351-25-000005.md) | [0.0](/filings/0000929351-26-000031.md) | [(0.1)](/filings/0001628280-26-054565.md) | [0.4](/filings/0000929351-26-000054.md) | [0.0 d](/filings/0000929351-26-000011.md) | [(3.2)](/filings/0000929351-26-000031.md) | [(1.2)](/filings/0001628280-26-054565.md) | [(1.7)](/filings/0000929351-26-000054.md) |
| Net income | $m | [(107)](/filings/0000929351-25-000005.md) | [148 d](/filings/0000929351-26-000011.md) | [4.2](/filings/0000929351-25-000142.md) | [(30.6)](/filings/0000929351-25-000142.md) | [(21.9)](/filings/0000929351-25-000005.md) | [(153)](/filings/0000929351-26-000054.md) | [(42.5)](/filings/0001628280-26-054565.md) | [(52.6)](/filings/0000929351-26-000054.md) | [(20.7) d](/filings/0000929351-26-000011.md) | [(165)](/filings/0000929351-26-000054.md) | [(189)](/filings/0000929351-26-000054.md) | [(34.8)](/filings/0000929351-26-000054.md) |
| Diluted EPS | $ per share | [(0.45)](/filings/0000929351-25-000005.md) | not reported | [0.26](/filings/0000929351-25-000103.md) | [(1.83)](/filings/0000929351-25-000142.md) | [(0.09)](/filings/0000929351-25-000005.md) | [(9.15)](/filings/0000929351-26-000031.md) | [(2.54)](/filings/0001628280-26-054565.md) | [(3.15)](/filings/0000929351-26-000054.md) | not reported | [(9.83)](/filings/0000929351-26-000031.md) | [(11.27)](/filings/0001628280-26-054565.md) | [(2.02)](/filings/0000929351-26-000054.md) |
| Basic EPS | $ per share | [(0.45)](/filings/0000929351-25-000005.md) | not reported | [0.26](/filings/0000929351-25-000103.md) | [(1.83)](/filings/0000929351-25-000142.md) | [(0.09)](/filings/0000929351-25-000005.md) | [(9.15)](/filings/0000929351-26-000031.md) | [(2.54)](/filings/0001628280-26-054565.md) | [(3.15)](/filings/0000929351-26-000054.md) | not reported | [(9.83)](/filings/0000929351-26-000031.md) | [(11.27)](/filings/0001628280-26-054565.md) | [(2.02)](/filings/0000929351-26-000054.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2024 (2023-12-31) | FY2024 (2024-03-31) | Q1 FY2025 (2024-06-30) | Q2 FY2025 (2024-09-30) | Q3 FY2025 (2024-12-31) | FY2025 (2025-03-31) | Q1 FY2026 (2025-06-30) | Q2 FY2026 (2025-09-30) | FY2026 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2027 (2026-06-30) | Q3 FY2027 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [283](/filings/0000929351-24-000006.md) | [23.0](/filings/0000929351-25-000038.md) | [193](/filings/0000929351-24-000017.md) | [230](/filings/0000929351-24-000023.md) | [201](/filings/0000929351-25-000005.md) | [17.8](/filings/0000929351-26-000011.md) | [51.6](/filings/0000929351-25-000103.md) | [37.0](/filings/0000929351-25-000142.md) | [35.7](/filings/0000929351-26-000054.md) | [102](/filings/0000929351-26-000031.md) | [59.6](/filings/0001628280-26-054565.md) | [86.8](/filings/0000929351-26-000054.md) |
| Current assets | $m | [1,526](/filings/0000929351-24-000006.md) | [127](/filings/0000929351-25-000038.md) | [1,244](/filings/0000929351-24-000017.md) | [1,153](/filings/0000929351-24-000023.md) | [1,071](/filings/0000929351-25-000005.md) | [171](/filings/0000929351-26-000011.md) | [123](/filings/0000929351-25-000103.md) | [114](/filings/0000929351-25-000142.md) | [132](/filings/0000929351-26-000054.md) | [195](/filings/0000929351-26-000031.md) | [151](/filings/0001628280-26-054565.md) | [164](/filings/0000929351-26-000054.md) |
| Total assets | $m | [7,155](/filings/0000929351-24-000006.md) | [2,139](/filings/0000929351-25-000038.md) | [7,222](/filings/0000929351-24-000017.md) | [7,147](/filings/0000929351-24-000023.md) | [7,167](/filings/0000929351-25-000005.md) | [2,173](/filings/0000929351-26-000011.md) | [2,092](/filings/0000929351-25-000103.md) | [1,972](/filings/0000929351-25-000142.md) | [1,913](/filings/0000929351-26-000054.md) | [1,789](/filings/0000929351-26-000031.md) | [1,672](/filings/0001628280-26-054565.md) | [1,594](/filings/0000929351-26-000054.md) |
| Current liabilities | $m | [3,172](/filings/0000929351-24-000006.md) | [408](/filings/0000929351-25-000038.md) | [4,134](/filings/0000929351-24-000017.md) | [3,791](/filings/0000929351-24-000023.md) | [3,400](/filings/0000929351-25-000005.md) | [623](/filings/0000929351-26-000011.md) | [677](/filings/0000929351-25-000103.md) | [600](/filings/0000929351-25-000142.md) | [539](/filings/0000929351-26-000054.md) | [628](/filings/0000929351-26-000031.md) | [596](/filings/0001628280-26-054565.md) | [493](/filings/0000929351-26-000054.md) |
| Total liabilities | $m | [7,069](/filings/0000929351-24-000006.md) | [1,220](/filings/0000929351-25-000038.md) | [7,148](/filings/0000929351-24-000017.md) | [7,272](/filings/0000929351-24-000023.md) | [7,324](/filings/0000929351-25-000005.md) | [1,407](/filings/0000929351-26-000011.md) | [1,379](/filings/0000929351-25-000103.md) | [1,309](/filings/0000929351-25-000142.md) | [1,267](/filings/0000929351-26-000054.md) | [1,310](/filings/0000929351-26-000031.md) | [1,376](/filings/0001628280-26-054565.md) | [1,326](/filings/0000929351-26-000054.md) |
| Long-term debt | $m | [2,238](/filings/0000929351-24-000006.md) | [1,620](/filings/0000929351-25-000005.md) | [1,545](/filings/0000929351-24-000017.md) | [2,098](/filings/0000929351-24-000023.md) | [2,442](/filings/0000929351-25-000005.md) | [700](/filings/0000929351-26-000011.md) | [612](/filings/0000929351-25-000103.md) | [609](/filings/0000929351-25-000142.md) | [606](/filings/0000929351-26-000054.md) | [603](/filings/0000929351-26-000031.md) | [600](/filings/0001628280-26-054565.md) | [658](/filings/0000929351-26-000054.md) |
| Current portion of debt | $m | [50.3](/filings/0000929351-24-000006.md) | [860](/filings/0000929351-25-000005.md) | [650](/filings/0000929351-24-000017.md) | [363](/filings/0000929351-24-000023.md) | [119](/filings/0000929351-25-000005.md) | [0.0](/filings/0000929351-26-000011.md) | not reported | [3.8](/filings/0000929351-25-000142.md) | [7.5](/filings/0000929351-26-000054.md) | [11.3](/filings/0000929351-26-000031.md) | [15.0](/filings/0001628280-26-054565.md) | [20.2](/filings/0000929351-26-000054.md) |
| Shareholders' equity | $m | [(326)](/filings/0000929351-24-000006.md) | [919](/filings/0000929351-26-000011.md) | [973](/filings/0000929351-25-000142.md) | [936](/filings/0000929351-25-000142.md) | [911](/filings/0000929351-26-000054.md) | [766](/filings/0000929351-26-000054.md) | [712](/filings/0000929351-26-000054.md) | [663](/filings/0000929351-26-000054.md) | [646](/filings/0000929351-26-000054.md) | [479](/filings/0000929351-26-000054.md) | [296](/filings/0000929351-26-000054.md) | [269](/filings/0000929351-26-000054.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2024 (2023-12-31) | Q4 FY2024 (2024-03-31) | Q1 FY2025 (2024-06-30) | Q2 FY2025 (2024-09-30) | Q3 FY2025 (2024-12-31) | Q4 FY2025 (2025-03-31) | Q1 FY2026 (2025-06-30) | Q3 FY2026 (2025-09-30) | Q3 FY2026 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2027 (2026-06-30) | Q3 FY2027 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [71.1 d](/filings/0000929351-25-000005.md) | [(533) d](/filings/0000929351-26-000011.md) | [(33.5)](/filings/0000929351-25-000103.md) | [9.1 d](/filings/0000929351-25-000142.md) | [(335) d](/filings/0000929351-25-000005.md) | [(63.5)](/filings/0000929351-26-000031.md) | [65.4](/filings/0000929351-25-000103.md) | [(26.1) d](/filings/0000929351-26-000054.md) | [(21.4) d](/filings/0000929351-26-000011.md) | [73.2](/filings/0000929351-26-000031.md) | [(28.2) d](/filings/0001628280-26-054565.md) | [18.9 d](/filings/0000929351-26-000054.md) |
| Capital expenditure | $m | [6.4 d](/filings/0000929351-25-000005.md) | [(4.3) d](/filings/0000929351-26-000011.md) | [4.9](/filings/0000929351-25-000103.md) | [4.7 d](/filings/0000929351-25-000142.md) | [14.0 d](/filings/0000929351-25-000005.md) | [3.9](/filings/0000929351-26-000031.md) | [6.9](/filings/0000929351-25-000103.md) | [5.2 d](/filings/0000929351-26-000054.md) | [4.5 d](/filings/0000929351-26-000011.md) | [4.5](/filings/0000929351-26-000031.md) | [5.2 d](/filings/0001628280-26-054565.md) | [5.8 d](/filings/0000929351-26-000054.md) |
| Dividends paid | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Share repurchases | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: not reported
- Share repurchases: not reported

## Shares

| Line item | Unit | Q1 FY2024 (2023-06-30) | Q2 FY2024 (2023-09-30) | Q3 FY2024 (2023-12-31) | Q1 FY2025 (2024-06-30) | Q2 FY2025 (2024-09-30) | Q3 FY2025 (2024-12-31) | Q4 FY2025 (2025-03-31) | Q1 FY2026 (2025-06-30) | Q2 FY2026 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2027 (2026-06-30) | Q3 FY2027 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [230](/filings/0000929351-24-000017.md) | [234](/filings/0000929351-24-000023.md) | [235](/filings/0000929351-25-000005.md) | [16.7](/filings/0000929351-25-000103.md) | [16.7](/filings/0000929351-25-000142.md) | [240](/filings/0000929351-25-000005.md) | [16.7](/filings/0000929351-26-000031.md) | [16.7](/filings/0001628280-26-054565.md) | [16.7](/filings/0000929351-26-000054.md) | [16.8](/filings/0000929351-26-000031.md) | [16.8](/filings/0001628280-26-054565.md) | [17.2](/filings/0000929351-26-000054.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 17,258,567 at 2026-10-28, from the cover of the [10-Q filed 2026-10-29](/filings/0000929351-26-000054.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 29, 2026, 16:31 ET. No prices; not investment advice.